product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
other
product name :
Rat IgG2a Negative Control
catalog :
MCA1212
quantity :
1 ml
price :
115 USD
more info or order :
Bio-Rad product webpage
citations: 17
Reference
Han S, Li H, Kim M, Shlomchik M, Lee H. Kidney Proximal Tubular TLR9 Exacerbates Ischemic Acute Kidney Injury. J Immunol. 2018;201:1073-1085 pubmed publisher
Marshall J, Sun Y, Bangari D, Budman E, Park H, Nietupski J, et al. CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease. Mol Ther. 2016;24:1019-1029 pubmed publisher
Olsson A, Nakhlé J, Sundstedt A, Plas P, Bauchet A, Pierron V, et al. Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment. J Immunother Cancer. 2015;3:53 pubmed publisher
Du J, Shen X, Hu X, Sun B, Guan W, Li S, et al. Wip1-deficient neutrophils significantly promote intestinal ischemia/reperfusion injury in mice. Curr Mol Med. 2015;15:100-8 pubmed
Ham A, Rabadi M, Kim M, Brown K, Ma Z, D AGATI V, et al. Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2014;307:F1052-62 pubmed publisher
Kim M, Ham A, Kim J, Brown K, D Agati V, Lee H. The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int. 2013;84:90-103 pubmed publisher
Lee H, Kim M, Kim J, Brown K, Ham A, D Agati V, et al. Critical role of interleukin-17A in murine intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2013;304:G12-25 pubmed publisher
Piccinini A, Midwood K. Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep. 2012;2:914-26 pubmed publisher
Park S, Kim J, Ham A, Brown K, Kim M, D Agati V, et al. A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2012;303:F721-32 pubmed publisher
Kim M, Park S, Kim M, D Agati V, Lee H. Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-?1 generation. Ann Surg. 2012;255:492-503 pubmed publisher
Anzinger J, Chang J, Xu Q, Barthwal M, Bohnacker T, Wymann M, et al. Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3K?-dependent fluid-phase pinocytosis of native LDL. J Lipid Res. 2012;53:34-42 pubmed publisher
Menzies F, Henriquez F, Alexander J, Roberts C. Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology. 2011;134:281-91 pubmed publisher
Park S, Kim M, Kim M, D Agati V, Lee H. Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int. 2011;80:1315-27 pubmed publisher
Kim M, Park S, Kim M, Chen S, Gerthoffer W, D Agati V, et al. Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol. 2010;299:F347-58 pubmed publisher
Ng H, Chiang S, Chi Y, Lee S. Identification of macrosialin (CD68) on the surface of host macrophages as the receptor for the intercellular adhesive molecule (ICAM-L) of Leishmania amazonensis. Int J Parasitol. 2009;39:1539-50 pubmed publisher
McConnell M, Huang Y, Datwani A, Shatz C. H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. Proc Natl Acad Sci U S A. 2009;106:6784-9 pubmed publisher
Kim M, Chen S, Park S, Kim M, D Agati V, Yang J, et al. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int. 2009;75:809-23 pubmed publisher
image
image 1 :
Bio-Rad MCA1212 image 1
Figure A. A647 conjugated Rat anti Mouse CD45R ( MCA1258A647 ) and RPE conjugated Rat IgG2a isotype control ( MCA1212PE ). Figure B. A647 conjugated Rat anti Mouse CD45R ( MCA1258A647 ) and RPE conjugated Rat anti mouse CD40 ( MCA1143PE ). All experiments performed on mouse splenocytes in the presence of mouse SeroBlock ( BUF041A )
product information
Entity Type :
Negative/Isotype Control
Entity Category :
Antibodies
ProductCode :
MCA1212
Description :
Rat IgG2a Negative Control
Specificity :
Rat IgG2a Negative Control
TargetSpecies :
Negative Control
Host :
Rat
Format :
Purified
Isotypes :
IgG2a
Applications :
F,C,E
ApplicationTypes :
Flow Cytometry,Immunohistology - Frozen,ELISA
Quantity :
1 ml
Quantity Value :
1
Quantity Type :
ml
Entity Formats :
Alexa Fluor® 405,Alexa Fluor® 488,Alexa Fluor® 647,Biotin,FITC,Low Endotoxin,Pacific Blue®,Purified,RPE,Alexa Fluor® 700
UNSPSC :
41116161
Concentration :
IgG concentration 0.1 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
87
PriceEUR :
121
PriceUSD :
115 USD
PriceCHF :
132
PriceSEK :
1319
PriceNOK :
1325
PriceDKK :
902
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.